Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems
Appl. Phys. Lett. 90, 213902 (2007); doi:10.1063/1.2742324
Published 24 May 2007
You are not logged in to this journal. Log in
We report on the toxicity of ZnO nanoparticles (NPs) to gram-negative and gram-positive bacterial systems, Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), and primary human immune cells. ZnO NP (~13 nm) showed complete inhibition of E. coli growth at concentrations
3.4 mM, whereas growth of S. aureus was completely inhibited for
1 mM. Parallel experiments using flow cytometry based assays clearly demonstrated that growth inhibitory properties of ZnO NP were accompanied by a corresponding loss of cell viability. Identical ZnO NP had minimal effects on primary human T cell viability at concentrations toxic to both gram-negative and gram-positive bacteria. Collectively, these experiments demonstrate selectivity in the toxic nature of ZnO NP to different bacterial systems and human T lymphocytes. Developing selective toxicity to biological systems and controlling it by NP design could lead to biomedical and antibacterial applications.
©2007 American Institute of Physics
3.4 mM, whereas growth of S. aureus was completely inhibited for
1 mM. Parallel experiments using flow cytometry based assays clearly demonstrated that growth inhibitory properties of ZnO NP were accompanied by a corresponding loss of cell viability. Identical ZnO NP had minimal effects on primary human T cell viability at concentrations toxic to both gram-negative and gram-positive bacteria. Collectively, these experiments demonstrate selectivity in the toxic nature of ZnO NP to different bacterial systems and human T lymphocytes. Developing selective toxicity to biological systems and controlling it by NP design could lead to biomedical and antibacterial applications.
©2007 American Institute of Physics
| History: | Received 8 March 2007; accepted 30 April 2007; published 24 May 2007 |
| Permalink: |
http://link.aip.org/link/?APPLAB/90/213902/1 |
KEYWORDS and PACS
RELATED DATABASES
PUBLICATION DATA
0003-6951 (print)
1077-3118 (online)
REFERENCES (14)
For access to fully linked references, you need to log in.
For access to fully linked references, you need to Log in.
- S. E. McNeil,
J. Leukoc Biol. 78, 585 (2005) . - J. K. Jaiswal and S. M. Simon,
Trends Cell Biol. 14, 497 (2004) . - T. K. Jain, M. A. Morales, S. K. Sahoo, D. L. Leslie-Pelecky, and V. Labhasetwar, Molecular Pharmaceutics 2, 194 (2005).
- R. K. Visaria, R. J. Griffin, B. W. Williams, E. S. Ebbini, G. F. Paciotti, C. W. Song, and J. C. Bischof, Mol Cancer Ther. 5, 1014 (2006).
- A. Nel, T. Xia, L. Madler, and N. Li,
Science 311, 622 (2006) . - T. C. Long, N. Saleh, R. D. Tilton, G. V. Lowry, and B. Veronesi,
Environ. Sci. Technol. 40, 4346 (2006) . - R. Brayner, R. Ferrari-Iliou, N. Brivois, S. Djediat, M. F. Benedetti, and F. Fievet,
Nano Lett. 6, 866 (2006) . - A. Thill, O. Zeyons, O. Spalla, F. Chauvat, J. Rose, M. Auffan, and A. M. Flank,
Environ. Sci. Technol. 40, 6151 (2006) . - C. Feldmann and H. O. Jungk,
Angew. Chem., Int. Ed. 40, 359 (2001) . - J. E. Coligan, Current Protocols in Immunology (Wiley-Interscience, New York, 1995), Vol. 1, Chap. 5.
- A. Punnoose, H. Magnone, M. S. Seehra, and J. Bonevich, Phys. Rev. B 64, 174420 (2001).
- C. E. Outten and O'Halloran,
Science 292, 2488 (2001) . - J. A. Lindsay and S. J. Foster, Acta Phys. Univ. Comenianae 147, 1259 (2001).
- A. Xiong and R. K. Jayaswal,
J. Bacteriol. 180, 4024 (1998) .







